FDA Inspection
Lydie L. Hazan, M.D.Lydie L. Hazan, M.D. – FDA Inspection, Apr 26, 2010
Record Details
This FDA Inspection record concerns Lydie L. Hazan, M.D., with an inspection on April 26, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lydie L. Hazan, M.D.
- Inspection Date
- April 26, 2010
- Product Type
- Drugs
View Company Profile
ID · dbb2694b-d2e5-4dd5-81eb-e59325322cb1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 658026
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lydie L. Hazan, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 25, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 19, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 11, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Lydie L. Hazan, M.D.
- FDA Inspection 1132614 - 2020-10-23
- FDA Inspection 914152 - 2015-02-25
- FDA Inspection 801048 - 2012-09-19
- FDA Inspection 645552 - 2010-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.